Heptagon Driehaus US MicroCapEqAEHEURAcc |
Performance History | 30/04/2024 |
Growth of 1,000 (EUR) |
Fund | 79.9 | 21.8 | -35.8 | 8.9 | 6.3 | |
+/-Cat | - | - | - | - | - | |
+/-Idx | - | - | - | - | - | |
Category: Other Equity | ||||||
Benchmarks: - |
Key Stats | ||
NAV 09/05/2024 | EUR 195.67 | |
Day Change | 0.85% | |
Morningstar Category™ | Other Equity | |
ISIN | IE00BDB53728 | |
Fund Size (Mil) 09/05/2024 | USD 834.49 | |
Share Class Size (Mil) 09/05/2024 | EUR 0.11 | |
Max Initial Charge | 3.00% | |
Ongoing Charge 01/01/2024 | 1.70% |
Investment Objective: Heptagon Driehaus US MicroCapEqAEHEURAcc |
The investment objective of the Fund is to achieve long-term capital growth. The Fund uses a growth style of investment in equity securities, whereby the Sub-Investment Manager seeks out investments with good growth potential. Under normal market conditions, the Fund will invest at least 80% of its net assets in the equity securities, including common and preferred stocks, of U.S. micro-capitalization (“micro-cap”) companies. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Jeffrey James 07/12/2016 | ||
Michael Buck 07/12/2016 | ||
Click here to see others | ||
Inception Date 06/11/2018 |
Advertisement |
Benchmarks | |
Fund Benchmark | Morningstar Benchmark |
Russell Micro Cap Growth TR USD | - |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Heptagon Driehaus US MicroCapEqAEHEURAcc | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Crinetics Pharmaceuticals Inc | Healthcare | 2.96 |
Modine Manufacturing Co | Consumer Cyclical | 2.66 |
Camtek Ltd | Technology | 2.24 |
FTAI Aviation Ltd | Industrials | 2.22 |
Xenon Pharmaceuticals Inc | Healthcare | 1.91 |
Increase Decrease New since last portfolio | ||
Heptagon Driehaus US MicroCapEqAEHEURAcc |